Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1949-1967
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1949
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1949
Figure 4 Overexpression of ELL-associated factor 2 inhibits the invasion and migration of RKO cells.
A: Protein levels of ELL-associated factor 2 (EAF2) in RKO cells transfected with EAF2 overexpression vector by western blot assay; B: Invasion and migration abilities evaluated by transwell assay; C: Migration ability analyzed by wound healing assay after 72 h; D: Migration and invasion abilities of RKO cells measured using ImageJ software. The data are shown as the mean ± SD. aP < 0.001; bP < 0.05. RKO-C: The group of RKO control cells; EAF2-OV: The group of RKO cells transfected with ELL-associated factor 2 overexpression vector; EAF2-NC: The group of RKO cells transfected empty vector; EAF2: ELL-associated factor 2; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Feng ML, Wu C, Zhang HJ, Zhou H, Jiao TW, Liu MY, Sun MJ. Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer. World J Gastrointest Oncol 2022; 14(10): 1949-1967
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1949.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.1949